Introduction
The global incidence of bronchial asthma is on the rise, and primary health-care institutions, as the backbone of the health system, are responsible for the initial and day-to-day management of a large number of asthma patients. Given the complexity of the asthma outbreak and the limitations in some aspects of a single Western or Chinese treatment, the combination treatment model of Western and Central medicine has important application value and practical significance at the grass-roots level.
II. West medicine for bronchial asthma
1. Drug treatment
– bronchial suffix: Short-acting β2 receptor agonizer (e.g. salbutamol) is the first drug of choice to mitigate acute asthma, to ease air-path smoothing muscles quickly and to mitigate the symptoms of asthma, air stress, etc. Long-acting β2 receptor agonists (e.g., salmetero) are used mainly for long-term asthma control, combined with inhaled sugar cortex hormones, which enhances therapeutic efficacy and reduces hormone use. Anticholine drugs (e.g., ammonium isopropobromoammonium) can also stretch gas tracts and are often used in combination with β2 receptor agonists for treatment of acute onset, especially for elderly patients or for those who combine chronic obstructive pulmonary disease.
– Sugar cortex hormones: Inhalation of sugar cortex hormones (e.g., Boudinaid) is a core drug for long-term control of asthma and has a strong anti-inflammation effect, which is effective in reducing respiratory inflammation, reducing the high responsiveness of the aromatic tract and reducing the frequency and severity of asthma. For persons with moderate severe asthma, oral or intravenous use of sugary cortex hormones may be required, but long-term use of whole-body hormones can have more adverse effects and require careful trade-offs.
– White tritole regulater (e.g. Monust): Interrupting the biological activity of white tritole, mitigating aromatic inflammation and convulsions, applicable to asthma patients with aspirin, motor asthma, and sensitive nasal inflammation, can be used alone or in conjunction with inhalation of sugar cortex hormones as an aid to asthma.
2. Treatment during acute onset
– Short-acting β2 receptor agonists, such as salbutamol aerosols, may be re-used for hours, if necessary; moderate dyslexia, in addition to bronchial condensants, shall be supplemented by inhaled sugar cortex hormones, which may be oral sugar cortex hormones if the treatment is not effective; and acute to critical dysentery, which requires immediate oxygen inhalation, continuous mistification of inhalation of bronchophagus, as well as the use of glucose hormonal hormones at the earliest possible time for intravenous use, while preparing for rescue, such as mechanical ventilation.
III. Chinese medical treatment for bronchial asthma
1. Proof of jurisdiction
– Date of launch:
– Testimonies of cold and cold, cold and cold, smooth tongues, and tight veins; It spreads the cold with a warm lung, flattens the asthma and shoots ephedrine down in Tonga.
– Proofs of hot-throwing, groaning in the throat, high-bursting, coughing, yellow or white coughing, slimy, adverse excretion, bitterness, thirst and drink, sweating out, skinning, or hot, moist, red, silky or stringy. Heated pulmonary aroma, strangulation, and strangulation of Tonga.
– Mitigation period:
– Testimony of low-temperature, low-temperature, low-temperature larynx, low-temperature, white-coloured, sweaty, windy, prone to cold, wearyness, low-eating, low-temperature, low-temperature, low-temperature, low-temperature, low-temperature, low-temperature, soft-temperature. To be treated with a good temper, to be paid for indignity, to be reduced by Tonga’s six men.
– Two false proofs of pulmonary kidneys: short-temperature and movement, adverse inhalation, scintillation of cough, concussion of the head, constriction of the knee, panic, indulging or intoxication, red red, dry mouth, red tongue, fine veins, or cold limbs, pale color, white tongue, fatness and thin veins. Healing to replete the kidneys of the pulmonary graft, which is added to and reduced by the life-spirited yellow soup alloy.
2. Chinese medical treatment
– Acupuncture: The use of acupunctures, spleen, kidneys, tungstens and three-mile-square positions as a means of cooling, strengthening and regulating the function of obscenity, which can be used in the management of asthma relief periods, enhancing the body ‘ s resilience and reducing the number of asthma attacks.
– Cave patches: known as the “triple volts” “39-sums”, which are made of white mustards, tsin, Gansu, Yenhuso, etc., which are applied to the pulmonary, heart, tungsten, tunghuso, tungsten latifling in three volts or three or nine days, which stimulates the flow of blood, regulates the body’s virulence, enhances the body’s immunity and has a better preventive and curative effect on asthma, especially in the cold.
– Drilling cans: canning cans in parts of the back, such as bladders, which can be used as an auxiliary treatment to improve the pulmonary function and clinical symptoms of asthma patients, with a view to facilitating communication, aerodynamic blood, and a chill.
IV. Advantage of Chinese-Western medical combinations for bronchial asthma
1. Synergy: Midwest and West care combined can build on the respective strengths of West and Central China. For example, during acute asthma, bronchial scalants and sugary cortex hormones from the Western Medical Service are able to mitigate symptoms quickly, while the Chinese Medical Service ‘ s evidence-based treatment can be based on patient-specific evidence, while the internal environment of the machine is tempered, the body ‘ s sensitivity to Western medicine is enhanced, the effect of treatment is enhanced and the symptoms are mitigated more quickly and thoroughly.
Reducing the adverse effects of Western medicine: The long-term use of inhaled sugar cortex hormones can lead to adverse effects such as oral pyrocococcus infections, acoustic acoustic noises and osteoporosis, while Chinese medicine ‘ s pro-conservative solid drugs (e.g. yellow tungsten, party membership, pheasant, etc.) can regulate the body ‘ s immune function, enhance the patient ‘ s body, reduce to some extent the adverse effects of hormones and increase the patient ‘ s dependence on drug treatment.
3. Improving the quality of life of patients: Chinese medicine is based on a holistic approach and on the identification and treatment of the symptoms of asthma, as well as on the management of the health, mental state and diet. Comprehensive measures such as birth-care guidance, emotional management and rehabilitation and exercise by the Chinese doctor can improve the overall health of patients, improve the quality of life and reduce the recurrence of asthma.
4. Prevention of asthma attacks: the Chinese doctor ‘ s lacquer, special therapy such as acupuncture, and the adjustment of Chinese medicine have had better preventive effects during asthma relief. By intervening during a given season or period of time to stimulate the body’s own ability to regulate, to enhance the body’s defensive function and to reduce the frequency and severity of asthma attacks, the Chinese doctor’s philosophy of “preventable” is reflected.
Integrated management of bronchial asthma in primary health-care institutions
1. Health education
– Medical personnel at the primary level should provide patients and their families with basic knowledge of bronchial asthma, including the causes of the disease, the mechanism for its occurrence, symptoms, treatment and preventive measures, so that the patient is aware that asthma is a controllable disease that requires long-term management, and so that the patient is more aware and able to manage itself.
– To guide patients in the proper use of inhaling devices, to ensure that drugs can be delivered effectively and to improve the effectiveness of drug treatment. At the same time, patients are informed about the adverse effects of drugs and how to deal with them, and the fear of drugs prevents them from being stopped or reduced.
– The teaching of early signs of asthma in patients and of simple emergency treatment measures, such as the immediate inhalation of salbutamol aerosols, so that timely measures can be taken to mitigate symptoms and prevent further deterioration in the early stages of the disease.
– Emphasis on everyday care, such as avoiding exposure to allergies (e.g. pollen, dust mites, pet hair, etc.), preventing respiratory infections, a reasonable diet, appropriate exercise and good mental health, to reduce the incentive for asthma.
2. Disease surveillance
– Establishment of patient health files, which provide a detailed record of basic information on patients, changes in conditions, treatment programmes and follow-up visits, etc., to inform long-term case management.
– Directing patients to self-situation, such as recording of asthma journals, including daily symptoms (e.g., asthma, air, cough, chest suffocation, etc.), frequency, severity, use of medication and possible induction factors, so that medical personnel can keep abreast of patient dynamics and adjust treatment programmes.
– Periodic pulmonary function check-ups of patients to assess the level of control of asthma and changes in pulmonary function, and general recommendations are made to perform lung function tests during the initial check-up, for three to six months after treatment and in case of a change in condition, to determine the effects of the treatment based on the results, to detect problems in a timely manner and to take appropriate measures.
3. Two-way referral
– Primary health-care institutions should establish a good two-way referral mechanism with higher-level hospitals, with clear instructions and procedures for referral. Patients with acute asthma symptoms, poor primary care or complications should be referred to higher hospitals in a timely manner for further diagnosis and treatment to ensure prompt and effective treatment.
– When a patient ‘ s condition is stabilized in a higher hospital, he/she can be referred back to the primary health-care facility for follow-up and management, and medical staff at the primary level continue to follow up on the patient in accordance with the treatment programme developed by the higher-level hospital, providing long-term medical care and health guidance, and providing continuity and overall management of the patient ‘ s treatment.
Conclusions
Primary health-care institutions play an important role in bronchial asthma prevention and treatment, and the West and Central medicine combination therapy model provides more comprehensive and effective treatment for asthma patients. Through the rational use of Western medicine and the comprehensive management of evidence, specialty therapy, combined with health education, disease surveillance and two-way referral, the treatment of bronchial asthma can significantly improve the effectiveness of the treatment, improve the quality of life of patients, reduce the rate of recurrence of disease and the cost of medical care, provide access to science, regulation and effective treatment and management in primary health-care institutions, promote the further development of bronchal asthma prevention and treatment at the grass-roots level, and increase the health well-being of the general population of asthma patients.
